-Jeremy G Richman Researcher Activity Profile

Research Author Detailed Information 

Jeremy G Richman Publication Rate By Year

Jeremy G Richman has published 8 paper(s) in 2007, for a total of 8 research publications in total.

Jeremy G Jg Richman Author Information

LAST NAME: richman

FIRST NAME: Jeremy G

INITIALS: jg

AFFILIATION:

Papers

Jeremy G Richman's Publication Record

1. Agonist lead identification for the high affinity niacin receptor GPR109a. Year Published: 2007
Department of Medicinal Chemistry, Arena Pharmaceuticals, San Diego, CA 92121, USA.
2. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. Year Published: 2007
Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA. pskinner@arenapharm.com
3. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Year Published: 2007
Department of Pharmacology, Merck Research Laboratories, Rahway, NJ, USA.
4. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Year Published: 2007
Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA.
5. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Year Published: 2007
Department of Pharmacology, Merck Research Laboratories, Rahway, NJ, USA. ester_carballojane@merck.com
6. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. Year Published: 2007
Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA. pskinner@arenapharm.com
7. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Year Published: 2007
Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA. pskinner@arenapharm.com
8. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Year Published: 2007
Department of Pharmacology, Merck Research Laboratories, Rahway, NJ, USA. ester_carballojane@merck.com